Grim Reaper 6 Posted September 21, 2021 #1 Share Posted September 21, 2021 Breaking News: Researchers at the University of Liverpool have shown how SARS-CoV-2 viral proteases attack the host cell, and how this can be targeted to stop virus replication in cell culture with drugs in current clinical use or in the pipeline. Both Bafetinib (an experimental cancer drug) and Sorafenib (an approved drug used to treat kidney and liver cancer) showed SARS-CoV-2 inhibition at concentrations that did not result in cytotoxicity in a human cell line model of infection. https://scitechdaily.com/stopping-coronavirus-replication-inhibiting-targets-of-sars-cov-2-proteases-can-block-infection/ 4 Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now